GLP-1 Weight-Loss Pens and Tirzepatide: Who They Suit and the Risks
Weight-loss pens really work, but they are not a shortcut without a cost, and they don't suit everyone. Here is the straight story on GLP-1 drugs and tirzepatide.


Key points
- Semaglutide and tirzepatide mimic gut hormones to reduce appetite; in major trials they cut body weight by an average of about 15% and about 20% respectively.
- They are for adults with obesity (BMI 30+) or BMI 27+ with weight-related disease (lower thresholds may apply for Asians), not for losing a few kilos for looks, and must be avoided with some conditions such as a family history of medullary thyroid cancer or pregnancy.
- Side effects are mostly digestive but can be serious (gallstones, pancreatitis, aspiration under anesthesia); most weight returns within a year of stopping, and fake pens sold online are dangerous.
Over the past few years, almost every week a patient asks me about "weight-loss pens". Some heard about them from friends; some bought them and injected themselves, then vomited so badly they had to come and see me. I want to give you straightforward information: these medicines genuinely help a lot, but they are not a shortcut without a price, and they don't suit everyone.
What are weight-loss pens and how do they work?
Weight-loss pens are prefilled pen injections given under the skin, mostly once a week. There are currently two main groups of medicine:
- GLP-1 receptor agonists, such as semaglutide (Wegovy for weight loss, Ozempic for diabetes) and liraglutide, an older medicine injected every day
- GIP/GLP-1 receptor agonist: tirzepatide (Mounjaro), which became available in Thailand from mid-2025
These medicines mimic hormones from the gut, so you feel full sooner and for longer, your appetite falls, your stomach empties more slowly, and blood sugar is better controlled.
How well do they work? Evidence from the key trials
| Study | Main result |
|---|---|
| STEP-1 (NEJM 2021) | Semaglutide 2.4 mg reduced weight by an average of about 15% over 68 weeks, compared with about 2% on placebo |
| SURMOUNT-1 (NEJM 2022) | The highest dose of tirzepatide reduced weight by an average of about 21% over 72 weeks |
| SURMOUNT-5 (NEJM 2025) | Head to head in people without diabetes, tirzepatide reduced weight by about 20% on average and semaglutide by about 14% |
| SELECT (NEJM 2023) | Semaglutide reduced major cardiovascular events by about 20% in people with overweight and existing heart disease, even without diabetes |
There is also evidence that they help obstructive sleep apnea in people with obesity and slow kidney disease in people with diabetes. These figures are "averages": some people lose a lot, others lose little.
Who they suit, and who they don't
In general, doctors consider them for adults who have:
- A body mass index (BMI) of 30 or more, or
- A BMI of 27 or more together with a weight-related condition, such as diabetes, high blood pressure, high cholesterol, fatty liver, knee osteoarthritis or sleep apnea
- In Asian people, doctors may use lower thresholds, because the risk of metabolic disease appears at a lower BMI than in Western populations
They should not be used, or need great caution, in these situations:
- A personal or family history of medullary thyroid cancer (MTC) or MEN2 syndrome
- Pregnancy, planning pregnancy or breastfeeding (stop the medicine before conceiving, as your doctor advises)
- Previous pancreatitis, gallbladder disease or severe gastroparesis (slow stomach emptying)
- A past or current eating disorder, such as anorexia or bulimia
- People who want to lose a small amount of weight for appearance without a medical indication
Side effects and risks you need to know
Common: nausea, vomiting, bloating, constipation and diarrhea, usually when starting or increasing the dose. That's why doctors increase the dose gradually every 4 weeks.
Less common but important:
- Gallstones and gallbladder inflammation, especially with rapid weight loss
- Pancreatitis: severe abdominal pain spreading to the back, with vomiting
- Dehydration from vomiting or diarrhea, which can worsen kidney function
- Low blood sugar, if used together with insulin or sulfonylurea medicines
- NAION, a loss of blood supply to the optic nerve, which the European Medicines Agency (EMA) concluded in 2025 is a very rare side effect of semaglutide. Sudden blurred vision or loss of vision needs a doctor immediately.
- A risk of aspiration under anesthesia, because the stomach empties slowly. Always tell your doctor before any surgery or endoscopy.
- Tirzepatide may reduce the effectiveness of oral contraceptive pills when starting and increasing the dose, so use an additional method of contraception.
Muscle loss: part of the weight lost is muscle, so you need enough protein and strength training alongside. See Nutrition after 50 and How much can TRT build muscle, and how to build muscle properly.
Common
On starting or raising dose
- Nausea, vomiting
- Bloating, constipation, diarrhea
Uncommon but important
- Gallstones, gallbladder inflammation
- Pancreatitis
- Dehydration, worsening kidney function
Tell your doctor
- Before surgery or endoscopy
- Sudden blurred vision (NAION)
- If using insulin or oral contraceptives
Muscle loss
- Eat enough protein
- Add strength training
Never buy injections from social media. WHO has warned about counterfeit pens.
What happens when you stop?
The SURMOUNT-4 study and the extension of STEP-1 found that when the medicine is stopped, most of the weight usually comes back within a year, because the medicine doesn't permanently change hunger signals. Obesity is therefore seen as a chronic disease: some people need long-term treatment, while others can reduce the dose once their habits have changed. Planning with your doctor from the start is important.
Weight, hormones and sexual health
Losing weight and belly fat raises testosterone in many men with obesity and helps erection problems related to blood vessels. Read more in Testosterone with diabetes, high blood pressure and chronic disease and Healthy fats: how to choose.
Care at Dr. Kris Clinic
Before starting, I assess your history, chronic conditions and current medicines, arrange necessary blood tests such as blood sugar, cholesterol, liver and kidney function, and discuss realistic goals. During treatment I follow up on side effects, adjust the dose and plan your diet and exercise. Everything is done only as assessed and prescribed by a doctor. English-speaking consultations are available.
Go to hospital immediately if you have severe abdominal pain that doesn't go away, vomiting so you can't eat or drink, yellow skin or eyes, sudden blurred vision or loss of vision, or faintness and palpitations from low blood sugar.
Medicines and services your doctor may consider
- Mounjaro 2.5 mg (starting dose)฿11,900Details & order →
- Mounjaro, all dosesSee pricesDetails & order →
Prices are per pack. Every medicine is prescribed only after a doctor's assessment; your doctor will advise whether it suits you. See all medicines & services
Want help with this? Three simple steps
Reading is a good start. When you are ready, check where you are, see how a consultation works, then book a time that suits you.
1Free 2-minute self-checkSexual-health self-check — see your result instantly and send it to the doctor if you like.Start the self-check →
2See the steps and feesIndividual from 990 THB · couple 1,590 THB · 30–60 minutes, at the clinic or online via MCS Telemedicine.How a consultation works →
3Book with the doctorPick a time online or message us on LINE. Come on your own or with your partner. Payment confirms the booking.Book online →Self-checks are a guide only and do not replace a doctor's assessment. Outcomes vary from person to person, depending on the severity of symptoms, the complexity of the problem and other factors.
Preventive health care
Plan check-ups, nutrition and supplements that fit your age and lifestyle.
Frequently asked questions
I'm not very overweight. Can I use a pen to lose 3–5 kilos?
Not recommended. These medicines are indicated for people with obesity, or overweight together with a related disease. Using them to lose a little weight isn't worth the risks and side effects.
Which works better, tirzepatide or semaglutide?
The 2025 SURMOUNT-5 study found tirzepatide reduced weight more on average, but the choice depends on your chronic conditions, side effects, availability and your doctor's assessment.
Will I need it for the rest of my life?
Not everyone, but many people regain weight when they stop. Plan with your doctor how long to use it, how to reduce the dose and how to keep your new habits going.
I need surgery or an endoscopy. Do I have to stop the medicine?
Always tell your doctor and anesthetist, because the medicine slows stomach emptying and raises the risk of aspiration. They will tell you whether to delay a dose or how to adjust fasting.
อ่านบทความนี้เป็นภาษาไทย
ปากกาลดน้ำหนัก GLP-1 และ Tirzepatide ใครเหมาะ ต้องระวังอะไร →
References
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384:989-1002.
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387:205-216.
- Aronne LJ, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5). N Engl J Med. 2025;393:26-36.
- Lincoff AM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). N Engl J Med. 2023;389:2221-2232.
- Aronne LJ, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction (SURMOUNT-4). JAMA. 2024;331(1):38-48.
- European Medicines Agency, PRAC. Conclusion that NAION is a very rare side effect of semaglutide medicines. June 2025.
This article is for education and does not replace diagnosis or treatment by a doctor. If you have symptoms or concerns, please see a doctor.










